UCB
Patients/ Views & Analysis/ Views and analysis
Success comes from listening to and working with patients
Amanda Barrell
Parkinson's, patient centricity, patient voice, UCB
0 Comment
NICE okays UCB’s Cimzia, nixes Almirall’s Ilumetri, in psoriasis
Richard Staines
Almirall, dermatology, NICE, psoriasis, UCB
0 Comment
News/ News/ Sales and Marketing
Amgen and UCB re-file Evenity for US approval
Piotr Wnuk
Amgen, Evenity, fda, monoclonal antibody, osteoporosis, UCB
0 Comment
FDA approves UCB’s Cimzia in plaque psoriasis
Linda Banks
Cimzia, dermatology, immuno-dermatology, psoriasis, skin condition, UCB
0 Comment
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis